Mandate

Vinge advises Active Biotech on real estate transaction

March 14, 2019 M&A

Active Biotech AB (publ) has entered an agreement regarding sale of the property Forskaren 1 in Lund, to an investor collective led by the real estate company Estea AB. The purchase price amounts to SEK 275 million. The transaction is subject to the general meeting’s approval. 

Vinge advises Active Biotech. Vinge’s team is primarily composed of Erik Sjöman, Anna Edström, Christian Lindhé and Jessica Salomonsson. 

Related

Vinge advises EQT in connection with the sale of Eton

Vinge has advised EQT VII in connection with its sale of Eton to a consortium of private investors.
July 01, 2025

Vinge advises Triton in connection with the acquisition of Prenax

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.
July 01, 2025

Vinge advises Impilo on the establishment of Impilo Healthcare

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Healthcare. The fund will have EUR 320m in commitments.
July 01, 2025